Ethical Profile
Mixed.
Not enough information to create an ethical profile.
Cingulate Inc..
CING.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Cingulate Inc. is a biopharmaceutical company focused on developing and commercializing novel therapeutics for attention deficit hyperactivity disorder (ADHD). Their primary focus is on developing and testing proprietary, once-daily, oral medications designed to improve the lives of patients with AD...Show More
Similar Companies
Value Scores
Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business40
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100
Better Health for All
0
No evidence available to assess Cingulate Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess Cingulate Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific, concrete data points for Cingulate Inc. (CING.US) related to Fair Pay & Worker Respect were found in the provided articles. Data for "CING.US (Cigna Group)" was present in one article, but this refers to a different company than Cingulate Inc.
1
Fair Trade & Ethical Sourcing
0
No evidence available to assess Cingulate Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess Cingulate Inc. on Honest & Fair Business.
Kind to Animals
0
The provided articles do not contain specific, concrete data points for any of the 'Kind to Animals' KPIs. While one article notes that the company 'Undertakes pre-clinical studies on animals to examine the safety profile of their medications,'
1
this fact alone does not provide the quantitative or policy-related details required by the rubric's thresholds for animal testing volume, policy, or the extent of alternative testing methods. Therefore, all KPIs are omitted due to a lack of explicit evidence.No War, No Weapons
0
Cingulate Inc. is a biopharmaceutical company focused on developing therapeutics for ADHD and anxiety. The provided article details a $3 million grant for a new anxiety treatment, with payments tied to development milestones and a royalty structure.
1
There is no evidence in the article to suggest any involvement in arms manufacturing, military contracts, dual-use technologies, or any other activities related to war or weapons. 2
Therefore, all KPIs under the 'No War, No Weapons' value are not applicable to the company based on the provided information. 3
Planet-Friendly Business
40
In 2023, the company's total Scope 1, 2, and 3 greenhouse gas emissions were 42.6 metric tons CO2 equivalent.
1
The material recovery rate for waste diversion was 92.4% in 2023. 2
Respect for Cultures & Communities
0
No specific, concrete evidence was found in the provided articles regarding Cingulate Inc.'s performance on any of the KPIs related to 'Respect for Cultures & Communities'. The articles primarily focus on financial results, clinical trial efficacy, and safety data for the company's drug candidates, and corporate governance structure, none of which contain information relevant to community engagement, cultural preservation, or related metrics.
Safe & Smart Tech
0
No evidence available to assess Cingulate Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No evidence available to assess Cingulate Inc. on Zero Waste & Sustainable Products.
Own Cingulate Inc.?
Upload your portfolio and see how all your holdings score across 11 ethical dimensions.
Audit My PortfolioAI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.